NCT02644759View on ClinicalTrials.gov

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2017

Study Completion Date

May 31, 2018

Conditions
Diabetes Mellitus Type 1Autoimmune DiseasesEndocrine System DiseasesGlucose Metabolism DisordersImmune System DiseasesMetabolic Diseases
Interventions
BIOLOGICAL

Stem Cell Transplantation

Interventional radiology-mediated transplantation of purified, autologous stem cells into pancreatic artery and capillaries, and intravenous injection of autologous, immunomodulated mononuclear cells.

Trial Locations (1)

11953

Stem Cells Arabia, Amman

All Listed Sponsors
lead

Stem Cells Arabia

OTHER

NCT02644759 - Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter